Catalogo Articoli (Spogli Riviste)

OPAC HELP

Titolo:
Effect of nonnicotine pharmacotherapy on smoking behavior
Autore:
Kotlyar, M; Golding, M; Hatsukami, DK; Jamerson, BD;
Indirizzi:
Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA Univ Minnesota Minneapolis MN USA 55455 rmacol, Minneapolis, MN 55455 USA Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA Univ Minnesota Minneapolis MN USA 55455 ychiat, Minneapolis, MN 55455 USA John Umstead Hosp, Butner, NC USA John Umstead Hosp Butner NC USAJohn Umstead Hosp, Butner, NC USA Univ N Carolina, Dept Psychiat, Chapel Hill, NC USA Univ N Carolina Chapel Hill NC USA a, Dept Psychiat, Chapel Hill, NC USA Glaxo Wellcome Inc, Res Triangle Pk, NC 27709 USA Glaxo Wellcome Inc Res Triangle Pk NC USA 27709 Triangle Pk, NC 27709 USA
Titolo Testata:
PHARMACOTHERAPY
fascicolo: 12, volume: 21, anno: 2001,
pagine: 1530 - 1548
SICI:
0277-0008(200112)21:12<1530:EONPOS>2.0.ZU;2-J
Fonte:
ISI
Lingua:
ENG
Soggetto:
DEFICIT HYPERACTIVITY DISORDER; SUSTAINED-RELEASE BUPROPION; REDUCES CIGARETTE-SMOKING; WITHDRAWAL SYMPTOMS; CONTROLLED TRIAL; DOUBLE-BLIND; TRANSDERMAL CLONIDINE; RANDOMIZED TRIAL; WEIGHT-GAIN; THERAPEUTIC USE;
Tipo documento:
Review
Natura:
Periodico
Settore Disciplinare:
Clinical Medicine
Citazioni:
138
Recensione:
Indirizzi per estratti:
Indirizzo: Kotlyar, M Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, 7-170 Weaver Densford Hall,308 Harvard St SE, Minneapolis, MN 55455 USA Univ Minnesota 7-170 Weaver Densford Hall,308 Harvard St SE Minneapolis MN USA 55455
Citazione:
M. Kotlyar et al., "Effect of nonnicotine pharmacotherapy on smoking behavior", PHARMACOTHE, 21(12), 2001, pp. 1530-1548

Abstract

Smoking-related disease is the single biggest preventable cause of morbidity and mortality in the United States, yet approximately 25% of Americans continue to smoke. Various dosage forms of nicotine replacement therapy increase smoking quit rates relative to placebo, but they generally do not result in 1-year quit rates of over 20%. To increase these rates, a number of nonnicotine agents have been investigated. Drugs that modulate noradrenergicneuro transmission (bupropion, nortriptyline, moclobemide) are more effective than those affecting serotonin (selective serotonin reuptake inhibitors, buspirone, ondansetron) or other neuro transmitters.

ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 19/02/20 alle ore 21:47:15